Location: http://www.accessdata.fda.gov/scripts/sda/sdNavigation.cfm?sd=clinicalinvestigatorsdisqualificationproceedings
Compliance and Enforcement
Regulatory Activities
Clinical Investigators - Disqualification Proceedings
Return to Introductory Page
Name Center Status Date of status Date NIDPOE Issued Date NOOH Issued Link to NIDPOE Letter Link to NOOH Letter Kleber, Ronald, MD
CDER
Disqualified
08/06/1981
07/16/1980
12/04/1980
Klein, Donald F., MD
CDER
Not Disqualified – Adequate Assurances1
03/14/1986
Kligman, Albert M., MD
CDER
Reinstated
08/19/1966
Kline, Nathan S., MD
CDER
Disqualified
11/13/1980
Knapp, Richard B., MD
CDER
Disqualified
11/04/1982
03/12/1982
Kornblith, Paul, MD
CBER
Disqualified
11/25/1991
05/29/1991
Kostas, Constantine I., MD
CDER
Disqualified
10/07/1986
Kumar, Anil, MD
CDER
Not Disqualified
05/02/2014
PDF
Kurland, Morton L., MD
CDER
Disqualified
11/06/1978
LaHaye, Leon C., MD
CDRH
Disqualified
06/18/2002
05/11/2001
01/08/2002
PDF Text
PDF Text Lamphier, Timothy A., MD
CDER
Disqualified
02/14/1979
Lapolla, Anthony, MD
CDER
Disqualified
05/05/1969
Lasala, Gabriel Perez, MD
CBER
Restricted
07/16/2013
02/16/2012
PDF Text
Law, Peter K., PhD
CBER
Disqualified
10/23/2006
06/30/2000
11/01/2002
PDF
PDF Text Levin, Harvey M., MD
CDER
Disqualified
02/01/1980
Levinson, Robert A., MD
CDER
Disqualified
03/31/1988
Levitt, Martin, MD
CDER
Restrictions Removed
05/02/1989
Lichty, Charles P., MD
CDER
Disqualified
12/23/2016
Lieberman, Ellin, MD
CBER
Disqualified
10/12/1993
02/23/1993
Linker, Charles A., MD
CDER
Restrictions Removed
05/18/1989
03/31/1988
Lippmann, Maurice, MD
Burea
Reinstated – Adequate Assurances1
11/05/1984
Lofgren, David Nils, MD
CBER
Disqualified
04/28/2008
11/09/2007
PDF Text
Loucks, David Craig, MD
CDER
Restricted
08/16/2010
08/18/2009
PDF Text
Lowe, Leo, MD
CDER
Disqualified
10/18/1966
Lu, Eugene, MD
CDER
Restricted
07/08/2010
03/16/2010
PDF Text
Macapinlac, Manuel, MD
CDER
Disqualified
08/26/2010
02/23/2009
04/19/2010
PDF Text
PDF Text Marcus, Eugenia, MD
CBER
Disqualified
10/03/2004
04/22/2004
PDF Text
Marker, Howard W., MD
CDER
Disqualified
10/08/2009
01/29/2009
PDF Text
Marquez, Farid, MD
CDER
Disqualified
08/06/2015
06/26/2015
PDF
Mathew, Chavaramplakil P., MD
CDER
Disqualified
09/24/2003
06/27/2001
06/03/2002
PDF Text
PDF Text McCracken, Elbert, MD
CBER
Disqualified
05/03/1977
07/12/1976
10/27/1976
McGee, J Michael, MD
CBER
Disqualified
01/08/2009
06/21/2001
05/21/2002
PDF
PDF Text McHardy, Gordon, MD
CDER
Reinstated
01/27/1969
McLeod, Jeffrey L., MD
CDER
Disqualified
09/29/2005
08/24/2005
PDF Text
Mendolia, Thomas Francis, DO
CDER
Disqualified
01/14/2014
11/22/2011
03/18/2013
PDF Text
Text Minton, Keith M., DO
CDER
Disqualified
01/26/1993
Mittelman, Abraham, MD
CBER
Restrictions Removed
12/09/1995
08/11/1993
12/27/1993
Mok, Martin S., MD
Burea
Not Disqualified – Adequate Assurances1
03/23/1983
Morton, Robert E., MD
CDER
Restricted
08/18/1988
Moskowitz, George, MD
CDER
Restrictions Removed
01/31/1986
05/20/1982
Musty, Richard E., MD, PhD
CDER
Restricted
09/20/1990
06/05/1990
Najarian, John S., MD
CBER
Restrictions Removed
11/17/1998
02/23/1993
12/30/1993
Niederman, Alan, MD
CBER
Restrictions Removed
07/25/2014
11/01/2010
PDF Text
Norman, Allyn M., DO
CDER
Disqualified
12/12/2002
06/27/2002
PDF Text
Novo, Felipe P., MD
CDER
Disqualified
11/04/1980
Nukta, Emad Dean, MD
CDRH
Restrictions Removed
03/26/2008
09/30/2004
PDA Text
Offenberg, Howard L., MD
CDER
Restricted
11/28/2005
06/08/2004
PDF Text
Ortiz, Julio A., MD
CDER
Disqualified
12/03/1980
Overlie, Paul A., MD
CDRH
Not Disqualified
10/12/2007
07/31/2007
PDF Text
Page, Roy C., MD
CBER
Disqualified
04/04/2003
04/06/2000
01/08/2002
PDF
PDF Text
Prev
|
Next
|
1
|
2
|
[3]
|
4
|
5
|
First
|
Last
|
All
1. Under regulations in effect until 1987, investigators who met the standard for disqualification (repeated or deliberate failure to comply with applicable requirements) could potentially avoid disqualification and continue to be eligible to receive investigational products if they could provide FDA with adequate assurances of future compliance with requirements applicable to the use of investigational drugs and biologics. The provisions for adequate assurances are no longer in the regulations.